Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 17/20 | 0.54 |
| ▸ | PPARG | P37231 | 14/20 | 0.54 |
| ▸ | PPARD | Q03181 | 12/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7247837 | 0.92 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL6544117 | 0.91 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL6542969 | 0.90 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL6544104 | 0.86 | PPARA (0.54) | PPARAPPARGPPARD | |
| SCHEMBL2437112 | 0.84 | PPARA (0.75) | PPARAPPARGPPARD | |
| SCHEMBL6544084 | 0.83 | PPARA (0.58) | PPARAPPARGPPARD | |
| SCHEMBL6543018 | 0.83 | PPARA (0.49) | PPARAPPARGPPARDNPC1 | |
| SCHEMBL6542809 | 0.82 | PPARA (0.67) | PPARAPPARGPPARDCXCR4 | |
| SCHEMBL6542970 | 0.82 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL2434140 | 0.81 | PPARA (0.61) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1433786-A1 | Benzoxazole compound and pharmaceutical composition containing the compound | Kowa Company Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-6653334-B1 | Electively activate peroxisome proliferator activated receptors | KOWA CO., LTD. (JP) | 2003-11-25 | — | — | US | disclosed |